Mostrar registro simples

dc.contributor.authorSáiz Vázquez, Olalla 
dc.contributor.authorPuente Martínez, Alicia
dc.contributor.authorPacheco Bonrostro, Joaquín 
dc.contributor.authorUbillos Landa, Silvia 
dc.date.accessioned2024-02-19T13:19:23Z
dc.date.available2024-02-19T13:19:23Z
dc.date.issued2023-01
dc.identifier.urihttp://hdl.handle.net/10259/8703
dc.description.abstractBackground: Alzheimer's disease (AD) is a neurological disorder of unknown cause, resulting in the death of brain cells. Identifying some of the modifiable risk factors for AD could be crucial for primary prevention and could lead to a reduction in the incidence of AD. Objective: This study aimed to perform a meta-meta-analysis of studies in order to assess the effect of blood pressure (BP) on the diagnosis of AD. Method: The search was restricted to meta-analyses assessing high systolic BP (SBP) and diastolic BP (DBP) and AD. We applied the PRISMA guidelines. Results: A total of 214 studies were identified from major databases. Finally, five meta-analyses (52 studies) were analyzed in this review. Results confirm that high SBP is associated with AD. The exploration of parameters (sex, age, study design, region, and BP measurements) shows that only region significantly moderates the relationship between BP and AD. Asian people are those whose SBP levels >140 mmHg are associated with AD. BP is associated with AD in both people aged ≤65 years and those aged ≥65 years and in cross-sectional and longitudinal studies. In the case of DBP, only women are at a higher risk of AD, particularly when its levels are >90. Conclusion: SBP is associated with both cerebrovascular disease and AD. Therefore, future studies should use other uncontrolled factors, such as cardiovascular diseases, diabetes, and stroke, to explain the relationship between SBP and AD.en
dc.description.sponsorshipThis study was partially funded by grant Y133GI awarded by the University of Burgos (Spain) to the Social Inclusion and Quality of Life (SIQoL) research group. This work was partially supported by FEDER funds and the Spanish State Research Agency (Projects PID2019-104263RB-C44 and PDC2021-121021-C22) and the Regional Government of “Castilla y León” and FEDER funds (Project BU056P20).en
dc.language.isoenges
dc.publisherFrontiers Mediaen
dc.relation.ispartofFrontiers in Neurology. 2023, V. 11en
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAlzheimer's diseaseen
dc.subjectBlood pressureen
dc.subjectSysto-diastolic hypertensionen
dc.subjectRisk factoren
dc.subjectMeta-analysisen
dc.subject.otherMedicinaes
dc.subject.otherMedicineen
dc.subject.otherSaludes
dc.subject.otherHealthen
dc.titleBlood pressure and Alzheimer's disease: A review of meta-analysisen
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.relation.publisherversionhttps://doi.org/10.3389/fneur.2022.1065335es
dc.identifier.doi10.3389/fneur.2022.1065335
dc.identifier.essn1664-2295
dc.journal.titleFrontiers in Neurologyen
dc.volume.number13es
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones


Arquivos deste item

Thumbnail

Este item aparece na(s) seguinte(s) coleção(s)

Mostrar registro simples